Works matching IS 18696953 AND DT 2025 AND VI 16 AND IP 1

Results: 9

Safety and Effectiveness of Glargine 300 U/ml After Switching from Basal Insulins in Patients with Type 1 Diabetes: COMET-T Study.
Published in:
Diabetes Therapy, 2025, v. 16, n. 1, p. 121, doi. 10.1007/s13300-024-01670-y
By:
- Gölz, Stefan;
- Mader, Julia K.;
- Bilz, Stefan;
- Kenzler, Julia;
- Danne, Thomas
Publication type:
Article
Publisher Correction to: Criteria for Personalised Choice of a Continuous Glucose Monitoring System: An Expert Opinion.
Published in:
2025
By:
- Di Molfetta, Sergio;
- Rossi, Antonio;
- Boscari, Federico;
- Irace, Concetta;
- Laviola, Luigi;
- Bruttomesso, Daniela
Publication type:
Correction Notice
Oral Semaglutide Use in Type 2 Diabetes: A Pooled Analysis of Clinical and Patient-Reported Outcomes from Seven PIONEER REAL Prospective Real-World Studies.
Published in:
Diabetes Therapy, 2025, v. 16, n. 1, p. 73, doi. 10.1007/s13300-024-01668-6
By:
- Rudofsky, Gottfried;
- Amadid, Hanan;
- Braae, Uffe Christian;
- Catrina, Sergiu-Bogdan;
- Kick, Anastas;
- Mandavya, Kabirdev;
- Roslind, Klaus;
- Saravanan, Ponnusamy;
- van Houtum, William;
- Jain, Akshay B.
Publication type:
Article
Cardiovascular Health Metrics of Spouses of Indian Women with a History of Gestational Diabetes and Diabetes in Pregnancy: Results from CHIP-F Study.
Published in:
Diabetes Therapy, 2025, v. 16, n. 1, p. 29, doi. 10.1007/s13300-024-01662-y
By:
- Gupta, Yashdeep;
- Goyal, Alpesh;
- Ambekar, Samita;
- Kalaivani, Mani;
- Bhatla, Neerja;
- Tandon, Nikhil
Publication type:
Article
The Impact of Comorbid Dementia and Diabetes Mellitus on Hospital Patients' Outcomes: A Systematic Review and Meta-analysis.
Published in:
Diabetes Therapy, 2025, v. 16, n. 1, p. 103, doi. 10.1007/s13300-024-01672-w
By:
- Gadsby-Davis, Kieran;
- Garner, Nikki;
- Ergin, Busra Donat;
- Dhatariya, Ketan;
- Hornberger, Michael
Publication type:
Article
Treatment Patterns and Glycaemic Control Between 2015 and 2019 in Tianjin, China: A Real-World Study of Adults with Type 2 Diabetes.
Published in:
Diabetes Therapy, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s13300-024-01661-z
By:
- Zhang, Qiumei;
- Fan, Yaqing;
- Liu, Xixi;
- Zhang, Minlu;
- Zhang, Jiewen;
- Du, Qin;
- Kang, Lei;
- Chen, Liming
Publication type:
Article
Risk Evaluation of Progression of Proteinuria and Renal Decline Based on a Novel Subgroup Classification in Chinese Patients with Type 2 Diabetes.
Published in:
Diabetes Therapy, 2025, v. 16, n. 1, p. 89, doi. 10.1007/s13300-024-01667-7
By:
- Wang, Kai;
- Qian, Qi;
- Bian, Chencheng;
- Sheng, Pei;
- Zhu, Lin;
- Teng, Shichao;
- An, Xiaofei
Publication type:
Article
Post Hoc Analysis of SURPASS-1 to -5: Efficacy and Safety of Tirzepatide in Adults with Type 2 Diabetes are Independent of Baseline Characteristics.
Published in:
Diabetes Therapy, 2025, v. 16, n. 1, p. 43, doi. 10.1007/s13300-024-01660-0
By:
- De Block, Christophe;
- Peleshok, Jennifer;
- Wilding, John P. H.;
- Kwan, Anita Y. M.;
- Rasouli, Neda;
- Maldonado, Juan M.;
- Wysham, Carol;
- Liu, Minzhi;
- Aleppo, Grazia;
- Benneyworth, Brian D.
Publication type:
Article
Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6.
Published in:
Diabetes Therapy, 2025, v. 16, n. 1, p. 15, doi. 10.1007/s13300-024-01659-7
By:
- Bain, Stephen C.;
- Belmar, Nicolas;
- Hoff, Søren T.;
- Husain, Mansoor;
- Rasmussen, Søren;
- Vilsbøll, Tina;
- Petrie, Mark C.
Publication type:
Article